Proteomics Market

The global proteomics market in terms of revenue was estimated to be worth $36.8 billion in 2023 and is poised to reach $72.9 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many proteomics-related research projects are also being fostered by increasing collaborative partnerships among various companies that are driving market growth.

Attractive Opportunities in the Proteomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Proteomics Market Dynamics

Driver: Technological Advancement in proteomics is likely to propel the market growth

The field of proteomics has been revolutionized by technological advancements that have greatly improved sensitivity and resolution, allowed for high-throughput and multiplexed analysis, facilitated data integration, enhanced sample preparation and fractionation techniques, enabled mass spectrometry-based imaging, and provided advanced data analysis and informatics tools. These advancements have played a pivotal role in driving the growth of the market by enabling a thorough and comprehensive understanding of the proteome. They have accelerated biomarker discovery, propelled advancements in personalized medicine, and facilitated drug discovery and development. These technological advancements have expanded the capabilities of proteomics research, enabling comprehensive and in-depth exploration of proteins in various biological contexts. They have led to breakthroughs in understanding protein functions, disease mechanisms, drug discovery, and personalized medicine, driving the growth and impact of proteomics as a field of study.

Restraint: High costs of proteomics instruments and technologies

The use of proteomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets to the characterization of protein-based products, toxicology, and the identification of surrogate markers of activity in clinical research to provide information on the mechanisms of drug action. This requires the use of different types of platforms and instruments and laboratory documentation systems, software, and databases, contributing to the high cost of protein analytics. Also, proteomics experiments require specialized expertise in sample preparation, data analysis, and interpretation. This expertise can be scarce and expensive to hire, particularly for smaller organizations. Thus, the high cost of instruments can affect the growth of the market itself. Limited adoption due to cost constraints can slow down market expansion, affecting the development of new technologies, innovation, and competition among instrument manufacturers.

Opportunity: High growth opportunities for proteomics research in emerging countries

The Asia Pacific region has witnessed significant advancements in proteomic technologies and methodologies. Researchers in the region have adopted cutting-edge techniques, such as mass spectrometry, protein profiling, and protein interaction analysis, to investigate complex biological systems. The availability of state-of-the-art proteomics platforms and instruments has contributed to the growth of proteomics research and applications. Governments in the Asia Pacific region have implemented supportive policies and initiatives to promote scientific research and innovation, including proteomics. These initiatives include research grants, funding programs, and regulatory frameworks that encourage proteomics research and its translation into practical applications. Government support has fostered a favorable environment for the growth of proteomics in the region. Increasing competition in mature markets also compels manufacturers to focus on emerging markets to ensure stable revenue growth in the coming years.

Challenge: Lack of data management/handling in proteomics research

Proteomics is a rapidly expanding field, aided by improvements in instrumentation accuracy and sensitivity, size, and affordability. This offers many possibilities for personalized and precision medicine, which could improve diagnosis, treatment, and disease management in the coming years. However, with the increase in proteome analysis, there is an inevitable increase in the volume of data generated. Thus, managing and handling proteomics data requires specialized expertise, resources, and infrastructure. Addressing these challenges is critical for advancing proteomics research. Hence, it can be considered as a challenge for the market.

Proteomics Market Ecosystem

The spectroscopy segment dominated the proteomics market in 2022.

Based on instrumentation technology, the market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. In 2022, spectroscopy accounted for the dominant share, segment's large share can be attributed to factors such as the increasing demand for spectroscopy techniques in proteomics research due to their ability to provide valuable insights into protein structure, dynamics, interactions, and functions. Furthermore, key market players are investing in drug discovery and development in the market is likely to spur the growth of the segment.

The immunoassay reagent segment of proteomics market is expected to grow at the highest CAGR during the forecast period.

Based on reagents, the market is broadly segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents, and other reagents. The immunoassay reagent segment is expected to register the highest CAGR during the forecast period. The large share of the immunoassay reagents segment is attributed to the greater availability of a wide range of reagents and the increased need for reliable, specific, and fast detection of diseases at the early stages.

North America dominated the proteomics market in 2022.

To know about the assumptions considered for the study, download the pdf brochure

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share in the proteomics market, followed by Europe and the Asia Pacific. The large share of the North American market is owing to various factors such presence of a large number of pharmaceutical companies and the growing demand for precision medicines. Increased research funding for proteomics is furthermore driving market growth in North America.

Key players in the market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US).

Proteomics Market Report Scope

This report categorizes the proteomics market to forecast revenue and analyze trends in each of the following submarkets:

By Instrumentation Technologies

• Spectroscopy
  • Mass Spectrometry
  • NMR Spectroscopy
  • CD Spectroscopy
• Chromatography
  • HPLC Chromatography
  • Ion Chromatography
  • Affinity Chromatography
  • Superficial Chromatography
• Electrophoresis
  • Gel Electrophoresis
  • Capillary Electrophoresis
• Protein Microarrays
  • Biochips
  • Microarray Instruments
• X-Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
• Other Technologies

By Reagent

• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents
• Other Reagents (Edman's reagent, enzymes, cross-linking agents)

By Software & Services

• Core Proteomics Services
• Bioinformatics Software & Services

By Application

• Clinical Diagnostics
• Drug Discovery & Development
• Other Applications

By End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic Research Laboratories
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments

• In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.
• In October 2022, Agilent Technologies Inc. and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.
• In November 2021, Thermo Fisher Scientific acquired Belgium-based Pharmafluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µpac portfolio of columns enhances liquid chromatography (lc) performance in biomarker, proteomics, and drug r&d applications, helping biotechnology and pharmaceutical companies uncover new insights and advance scientific discovery.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst